Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice explains that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T01:30:51.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T01:05:20.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:44:56.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6), reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-09-20T00:34:01.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    New Revision: v3.6.6 was added to the study record history and Revision: v3.6.5 was removed, updating the revision log to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-08-29T19:23:26.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the record history, replacing the previous v3.6.4. This reflects a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-08T11:18:26.000Z thumbnail image

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.